Heraeus Medical Components, a global business unit of Heraeus Holding, has finalised an agreement to acquire Via Biomedical, an outsourcing partner for medical device OEM companies.
Via Biomedical focuses on contract development, prototyping, processing and manufacturing of interventional devices.
The acquisition is the third technology acquisition in the last 24 months and Via Biomedical enables Heraeus to expand its capabilities within growing interventional device markets.
David Ohmann, executive vice president, Interventional Solutions at Heraeus added: “Via Biomedical has an impressive track record with their engineering agility. When you combine their strengths with our global reach and excellence in high-volume manufacturing, OEM medical device customers will be able to shorten development cycles and get innovative products to market faster."
Founded in 2001, Via Biomedical has core development competencies in catheters, balloons, stent delivery systems, moulded medical device products and assemblies regularly used in interventional cardiology, neurovascular, and peripheral vascular markets.
Nicolas Guggenheim, president of Heraeus Medical Components, said: “The acquisition of Via Biomedical is part of our continued investment to support our medical device customers in the vascular field.”
